%0 Generic
%A Ciruelos, E. M.
%A Ponce, J.
%A Pernas Simon, S.
%A Cortes, J.
%A Cantos, B.
%A Garate, E.
%A Vega Alonso, E.
%A Mele Olive, M.
%A Martinez De Duenas, E.
%A Montano Perianez, A.
%A Martinez, N.
%A Perello Martorell, A.
%A Bermejo De las Heras, B.
%A Arqueros Nunez, C.
%A Fernandez, I.
%A De la Haba Rodriguez, J.
%A Oliveira, M.
%A Gonzalez, X.
%A Villagrasa Gonzalez, P.
%A Prat, A.
%T SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician's choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+)/PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
%D 2022
%@ 0923-7534
%U http://hdl.handle.net/10668/21908
%~